Background: Intravenous pantoprazole is often administered inappropriately to hospitalized patients who can take oral medications.
Aim: To compare the antisecretory effects of oral rabeprazole and intravenous pantoprazole in healthy subjects.
Methods: In a double-blind, double-dummy, two-way crossover study, 38 Helicobacter pylori-negative volunteers were randomized to oral rabeprazole 20 mg or intravenous pantoprazole 40 mg daily for 3 days followed, after a 14-day washout period by the comparator treatment. Intragastric pH was recorded continuously for 24 h at baseline and on days 1 and 3 of each treatment period.
Results: The mean (95% CI) percentage of the 24-h recording with gastric pH >4 was higher with rabeprazole than with pantoprazole on day 1: 37.7% (30.6-44.8%) vs. 23.9% (20.0-27.8). The mean percentage times with pH >3 and >4 for all intervals assessed were greater and the median 24-h intragastric pH values were higher with rabeprazole than with pantoprazole on days 1 and 3. The mean acidity index was lower with rabeprazole on days 1 and 3.
Conclusions: Oral rabeprazole 20 mg produced greater acid suppression than intravenous pantoprazole 40 mg. Therefore, it may be an appropriate and effective alternative in patients who can take oral medication.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1365-2036.2006.03160.x | DOI Listing |
Radiol Case Rep
March 2025
Faculty of Medicine, Arab American University of Palestine, Jenin, Palestine.
Spontaneous cervical swelling syndrome is an uncommon clinical syndrome characterized by the sudden onset of swelling in the cervical region with no identifiable cause. A 47-year-old woman with a history of Iron Deficiency Anemia presented to the emergency department (ED) complaining of an acute left neck and upper chest swelling and pressure sensation in her neck. The swelling started suddenly and was growing rapidly over several hours.
View Article and Find Full Text PDFKidney Int Rep
October 2024
Department of Nephrology and Dialysis, Division of Medicine III, Medical University of Vienna, Vienna, Austria.
Introduction: Hemodialysis patients (HDPs) exhibit extensive cardiovascular risk. The widely prescribed anti-platelet agent clopidogrel is metabolically activated by cytochrome enzymes, which may be impaired by uremia and chronic low-grade inflammation, typically present in HDPs. We conducted a prospective multicenter study to investigate the pharmacokinetics and pharmacodynamics of clopidogrel in HDPs and healthy volunteers (HVs).
View Article and Find Full Text PDFCureus
July 2024
Internal Medicine, Sri Ramachandra Institute of Higher Education and Research, Chennai, IND.
Medicine (Baltimore)
August 2024
Department of Ophthalmology, Affiliated Hospital of Zunyi Medical University, Zunyi City, China.
Cureus
May 2024
Department of Infectious Diseases, Suleyman Demirel University, Isparta, TUR.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!